EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of the Safety Profile of Purified Pentadesma butyracea (Clusiaceae) Gum Intended as a Pharmaceutical Excipient

Mary-Ann Archer iD, Kwabena Ofori-Kwakye iD, Raphael Johnson iD, Ernest Amponsah Asiamah iD, Wisdom Ahlidja iD, Mustapha Abubakar Ahmed iD, Isaac Tabiri Henneh iD

Journal of Toxicology · 2026-01 · 2026 (1)

DOI: 10.1155/jt/4227246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Toxicology, online erschienen am 01.04.2026. Verfasst von Mary-Ann Archer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pentadesma butyracea (family Clusiaceae ) bark is widely used in traditional medicine across sub‐Saharan Africa. However, the investigation of the safety profile of the gum exudate obtained from the stem bark of the plant is undocumented. This study evaluated the acute and subacute toxicity of the purified Pentadesma butyracea gum (PBG) in 36 male Sprague Dawley rats (8–10 weeks old; 100–182.08 g) to determine its safety profile for potential use as a pharmaceutical excipient. Acute toxicity was assessed using a single oral dose of 2000 mg/kg PBG, while subacute toxicity involved daily administration of 250, 500, and 1000 mg/kg PBG for 28 days. In the acute toxicity study, no mortality or significant adverse effects on behavior, body weight, relative organ weight, or histological features were observed, suggesting an LD 50 greater than 2000 mg/kg PBG. Hematological and biochemical analyses revealed no harmful deviations, supporting the safety of PBG in acute exposure. In the subacute study, no mortality occurred across all doses, and body weight changes were minimal. Relative organ weights of the kidneys, heart, and lungs increased at higher doses, indicating potential dose‐dependent effects. Biochemical analyses revealed no significant alterations in liver enzymes (AST, ALT, and ALP) or markers of kidney function (urea and creatinine) at lower doses; however, slight elevations in bilirubin and creatinine were observed at 1000 mg/kg PBG, suggesting mild hepatic and renal stress. Histopathological analysis confirmed the absence of severe pathological changes, with only mild and reversible alterations at higher doses. Overall, PBG demonstrated a favorable safety profile at doses below 1000 mg/kg, supporting its potential use as a pharmaceutical excipient. The preliminary phytochemical screening also showed the presence of tannins, glycosides, coumarins, sterols, and triterpenoids. Further studies, including chronic toxicity and pharmacokinetic assessments, are recommended to establish the long‐term safety of PBG.

Schlagwörter

Stichwörter der Autor:innen

Pentadesma butyraceagumpharmaceutical excipientstoxicity profile

Autor:innen und Institutionen

  • Department of Pharmaceutics, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh.
  • Department of Pharmaceutics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, knust.edu.gh.
  • Department of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh.
  • Department of Pharmacotherapeutics and Pharmacy Practice, University of Cape Coast, Cape Coast, Ghana, ucc.edu.gh.

ORCID-Profile: Mary-Ann Archer, Kwabena Ofori-Kwakye, Raphael Johnson, Ernest Amponsah Asiamah, Wisdom Ahlidja, Mustapha Abubakar Ahmed, Isaac Tabiri Henneh

Zitieren

APA

Archer, M. A., Ofori-Kwakye, K., Johnson, R., Asiamah, E. A., Ahlidja, W., Ahmed, M. A., & Henneh, I. T. (2026). Assessment of the Safety Profile of Purified Pentadesma butyracea (Clusiaceae) Gum Intended as a Pharmaceutical Excipient. Journal of Toxicology, 2026(1). https://doi.org/10.1155/jt/4227246

Vancouver

Archer MA, Ofori-Kwakye K, Johnson R, Asiamah EA, Ahlidja W, Ahmed MA, et al. Assessment of the Safety Profile of Purified Pentadesma butyracea (Clusiaceae) Gum Intended as a Pharmaceutical Excipient. Journal of Toxicology. 2026;2026(1). doi:10.1155/jt/4227246

BibTeX
@article{Archer2026,
  author = {Archer, Mary-Ann and Ofori-Kwakye, Kwabena and Johnson, Raphael and Asiamah, Ernest Amponsah and Ahlidja, Wisdom and Ahmed, Mustapha Abubakar and Henneh, Isaac Tabiri},
  title = {Assessment of the Safety Profile of Purified Pentadesma butyracea (Clusiaceae) Gum Intended as a Pharmaceutical Excipient},
  journal = {Journal of Toxicology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jt/4227246}
}
Kostenlos starten →